Allogene Therapeutics

Allogene Therapeutics

Allogene Therapeutics

We are a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic CAR T therapy.
Raised
$324M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$324,000,000
IPO - 2018
Undisclosed amount
Undisclosed funding - 2018
Vida Ventures
Team Size
1–10
Employees
$324,000,000 IPO
PE HUB , Xconomy

VC-backed Allogene Therapeutics goes public

Undisclosed funding
PE HUB , FinSMEs

Allogene Therapeutics grabs funding from Vida Ventures

Funding